These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2564749)
1. Doses of muscle relaxants. Northwood D Anaesthesia; 1989 Feb; 44(2):172-3. PubMed ID: 2564749 [No Abstract] [Full Text] [Related]
2. Unequal effects of cardiopulmonary bypass-induced hypothermia on neuromuscular blockade from constant infusion of alcuronium, d-tubocurarine, pancuronium, and vecuronium. Buzello W; Schluermann D; Pollmaecher T; Spillner G Anesthesiology; 1987 Jun; 66(6):842-6. PubMed ID: 2884901 [No Abstract] [Full Text] [Related]
3. The interaction of neuromuscular relaxants with rabbit lung muscarinic receptors. Sugai Y; Sugai K; Mishima M; Okuda C; Miyazaki M Acta Anaesthesiol Scand; 1990 May; 34(4):249-52. PubMed ID: 1971473 [TBL] [Abstract][Full Text] [Related]
4. Intubating conditions following pre-induction priming with alcuronium. Harrop-Griffiths AW; Grounds RM; Moore M Anaesthesia; 1986 Mar; 41(3):282-6. PubMed ID: 3963331 [TBL] [Abstract][Full Text] [Related]
5. Recovery of neuromuscular function and postoperative morbidity following blockade by atracurium, alcuronium and vecuronium. Kong KL; Cooper GM Anaesthesia; 1988 Jun; 43(6):450-3. PubMed ID: 2900608 [TBL] [Abstract][Full Text] [Related]
6. [Atracurium--increased duration of its effect following alcuronium]. Janda A; Mühlsteiger B; Schwarz S Anasth Intensivther Notfallmed; 1990 Jun; 25(3):203-5. PubMed ID: 2393076 [TBL] [Abstract][Full Text] [Related]
7. [Dosage of diallyl-nor-toxiferine calculated on the basis of lean body mass]. Yamayoshi S; Yoshikawa K; Kawai T Masui; 1976 Feb; 25(2):120-6. PubMed ID: 943596 [No Abstract] [Full Text] [Related]
8. [Alcuronium (clinical experience with about 500 cases)]. Cristea H; Litarczek G; Darutzi A; Benţia L; Ghiga AR Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1974; 23(7):641-8. PubMed ID: 4283140 [No Abstract] [Full Text] [Related]
9. [Combination of non-depolarizing muscle relaxants. Studies in rats (author's transl)]. Plötz J; Weis KH; Decker R Anaesthesist; 1974 Apr; 23(4):197-201. PubMed ID: 4477695 [No Abstract] [Full Text] [Related]
10. Priming and the onset of neuromuscular blockade with alcuronium. Black AM; Hutton P; el-Hassan KM; Morgan G; Clutton-Brock TH Br J Anaesth; 1986 Aug; 58(8):827-33. PubMed ID: 3730230 [TBL] [Abstract][Full Text] [Related]
11. Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man. Krieg N; Crul JF; Booij LH Br J Anaesth; 1980 Aug; 52(8):783-8. PubMed ID: 6107097 [TBL] [Abstract][Full Text] [Related]
12. Plasma proteins, packed-cell volume and requirements for alcuronium. Yeung ML Br J Anaesth; 1976 Sep; 48(9):859-63. PubMed ID: 971391 [TBL] [Abstract][Full Text] [Related]
13. Priming with alcuronium and tubocurarine accelerates the onset of neuromuscular block. Pollard BJ Br J Anaesth; 1989 Jul; 63(1):7-11. PubMed ID: 2765345 [TBL] [Abstract][Full Text] [Related]
15. Recurarisation following a suxamethonium-alcuronium sequence in patients with atypical cholinesterase. Baraka A; Sibai AN; Hamed M; Delleh R Anaesthesia; 1988 Apr; 43(4):310-1. PubMed ID: 3377154 [TBL] [Abstract][Full Text] [Related]